Santhera Pharmaceuticals (Schweiz) AG

 Santhera Pharmaceuticals (Schweiz) AG contact information is shown below
Owner:SANTHERA PHARMACEUTICALS (SCHWEIZ) AG
Owner Address:Hohenrainstrasse 24 Pratteln 4133 Switzerland
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned bySanthera Pharmaceuticals (Schweiz) AG

Brand:

AGAMREE

Description:

Pharmaceutical preparations for the treatment of neuromuscular and inflammatory diseases;

Category: PHARMACEUTICAL PREPARATIONS TREATMENT
Brand:

CATENA

Description:

Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases; muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; reagents for medical use;Chemicals for use in industry and science; reagents for scientific and medical research use;Medical research; science research; medical and scientific research, namely conducting clinical trials; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; animal model testing and research for neuro-muscular and ophthalmological diseases;

Category: PHARMACEUTICAL PREPARATIONS TREATMENT
Brand:

CATENA

Description:

The mark consists of a circle design that contains a smaller circle to the right inside of the original circle. The circle design is followed by the word CATENA.;Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, and muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies;Color is not claimed as a feature of the mark.;Chemicals for use in industry and science; reagents for scientific and medical research use;Medical research; science research; medical and scientific research, namely, conducting clinical trials; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; animal model testing and research for neuro-muscular and ophthalmological diseases;

Category: